radiopharmtheranostics.com (RADX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Simbol lan logo merek Radiopharm Theranostics (RADX)

Radiopharm Theranostics (RADX) maintains a business model resilient to macroeconomic crises, as demand for oncology innovations remains constant. Operations are strictly regulated by radioactive waste disposal standards. The earnings per share (EPS) forecast for the coming year clearly demonstrates expert expectations, where the 0.00 indicator determines the parameter status. This reinforces the company's pricing power due to its ownership of rare isotopes used for the targeted destruction of cancer cells.

RADX: Prakiraan wutah bathi kanggo taun ngarep radiopharmtheranostics.com 06.12.2024 - 15.11.2026

RADX (Radiopharm Theranostics Ltd): rincian analitis lan laporan miturut indikator

Analisis fundamental perusahaan:RADX, Radiopharm Theranostics Limited
Produk dadi Radiopharm Theranostics Limited

When screening for issuer reliability, this indicator serves as a filter for market optimism regarding future profitability. It is calculated as the percentage ratio of the expected earnings per share (EPS) for the following year to the current value, reflecting the analysts' consensus forecast. For Radiopharm Theranostics (RADX), the forward growth vector of EPS for the coming year confirms the capitalization of the intellectual potential of nuclear medicine specialists and the stability of the research staff.

Karo sapa Radiopharm Theranostics saingan

ONC (BeiGene Ltd) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Halozyme Therapeutics HALO|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Revolution Medicines, Inc. (RVMD)|Prakiraan wutah bathi kanggo taun ngarep Ascentage Pharma Group International (AAPG)|Prakiraan wutah bathi kanggo taun ngarep CGON (CG Oncology Inc)|Dinamika bathi saben saham sing diarepake ing taun ngarep URGN|bicara.com - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep PSNL (personalis.com)|Erasca Inc (ERAS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Delcath Systems|YMAB (YmAbs) - Prakiraan wutah bathi kanggo taun ngarep|AURA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Candel Therapeutics, Inc. (CADL)|Prakiraan wutah bathi kanggo taun ngarep Accuray (ARAY)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CTOR - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|HURA: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|TARA (Protara) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Fate Therapeutics, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|WHWK (aadibio.com) - Prakiraan wutah bathi kanggo taun ngarep|TCRX: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Champions Oncology (CSBR)|XBiotech - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CEL-SCI CVM|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep OS Therapies (OSTX)|Artiva - Prakiraan wutah bathi kanggo taun ngarep|ANL: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|VERU: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep renovarobio.com RENB|Prakiraan wutah bathi resik saben saham kanggo taun ngarep muraloncology.com (MURA)|Proyeksi tambahing bathi saben saham ing taun ngarep KAPA|Prakiraan wutah bathi kanggo taun ngarep OKUR (onkuretherapeutics.com)|Proyeksi tambahing bathi saben saham ing taun ngarep GDTC (CytoMed)|Curis - Prakiraan wutah bathi kanggo taun ngarep|APLM: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Tharimmune (THAR) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Advanced Biomed Inc.|GNPX (Genprex Inc) - Prakiraan wutah bathi kanggo taun ngarep|Calidi Biotherapeutics (CLDI) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SBFM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep XBIO (Xenetic Biosciences, Inc.)|Prakiraan wutah bathi kanggo taun ngarep SLRX (salariuspharma.com)|PPBT - Prakiraan wutah bathi saben saham kanggo taun ngarep|AONC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BGNE (BeOne Medicines)|CKPT: Prakiraan wutah bathi kanggo taun ngarep|Elevation Oncology Inc. (ELEV) - Prakiraan wutah bathi kanggo taun ngarep|ICAD (iCAD) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ikenaoncology.com|Prakiraan wutah bathi kanggo taun ngarep NTBL|Prakiraan wutah bathi kanggo taun ngarep Viracta Therapeutics Inc. (VIRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MorphoSys Inc MOR|Dinamika bathi saben saham sing diarepake ing taun ngarep NAYA|AAPGV: Prakiraan wutah bathi saben saham kanggo taun ngarep